Literature DB >> 6289962

Acyclovir.

M C Timbury.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6289962      PMCID： PMC1499809          DOI： 10.1136/bmj.285.6350.1223

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  27 in total

1.  Acyclovir in herpes zoster.

Authors:  N A Peterslund; K Seyer-Hansen; J Ipsen; V Esmann; H Schonheyder; H Juhl
Journal:  Lancet       Date:  1981-10-17       Impact factor: 79.321

2.  A comparison of acyclovir and idoxuridine as treatment for ulcerative herpetic keratitis.

Authors:  D J Coster; K R Wilhelmus; R Michaud; B R Jones
Journal:  Br J Ophthalmol       Date:  1980-10       Impact factor: 4.638

3.  Comparative trial of acyclovir and adenine arabinoside in the treatment of herpes simplex corneal ulcers.

Authors:  J McGill; P Tormey; C B Walker
Journal:  Br J Ophthalmol       Date:  1981-09       Impact factor: 4.638

4.  Growth inhibition by acycloguanosine of herpesviruses isolated from human infections.

Authors:  C S Crumpacker; L E Schnipper; J A Zaia; M J Levin
Journal:  Antimicrob Agents Chemother       Date:  1979-05       Impact factor: 5.191

5.  Parenteral acyclovir therapy for herpesvirus infections in man.

Authors:  P J Selby; R L Powles; B Janeson; H E Kay; J G Watson; R Thornton; G Morgenstern; H M Clink; T J McElwain; H G Prentice; R Corringharn; M G Ross; A V Hoffbrand; D Brigden
Journal:  Lancet       Date:  1979-12-15       Impact factor: 79.321

6.  The activity in vitro against herpes virus of 9-(2-hydroxyethoxymethyl)guanine (acycloguanosine), a new antiviral agent.

Authors:  P Collins; D J Bauer
Journal:  J Antimicrob Chemother       Date:  1979-07       Impact factor: 5.790

7.  Acyclovir therapy for mucocutaneous herpes simplex infections in immunocompromised patients.

Authors:  C D Mitchell; B Bean; S R Gentry; K E Groth; J R Boen; H H Balfour
Journal:  Lancet       Date:  1981-06-27       Impact factor: 79.321

8.  Pathogenicity in mice of strains of herpes simplex virus which are resistant to acyclovir in vitro and in vivo.

Authors:  H J Field; G Darby
Journal:  Antimicrob Agents Chemother       Date:  1980-02       Impact factor: 5.191

9.  Randomised double-blind trial of acyclovir and idoxuridine in dendritic corneal ulceration.

Authors:  L M Collum; A Benedict-Smith; I B Hillary
Journal:  Br J Ophthalmol       Date:  1980-10       Impact factor: 4.638

10.  Acyclovir prophylaxis of herpes-simplex-virus infections.

Authors:  R Saral; W H Burns; O L Laskin; G W Santos; P S Lietman
Journal:  N Engl J Med       Date:  1981-07-09       Impact factor: 91.245
View more
  5 in total

1.  Acyclovir update.

Authors:  D J Jeffries
Journal:  Br Med J (Clin Res Ed)       Date:  1986-12-13

2.  Failure of acyclovir cream in treatment of recurrent herpes labialis.

Authors:  S Kingsley; J M Yeo; A P Fiddian; T Nebout; M Hantzperg
Journal:  Br Med J (Clin Res Ed)       Date:  1985-07-27

3.  Clinical use of acyclovir.

Authors:  D J Jeffries
Journal:  Br Med J (Clin Res Ed)       Date:  1985-01-19

4.  Meningitis and disseminated cutaneous zoster complicating herpes zoster infection.

Authors:  S J Karp
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-06       Impact factor: 10.154

5.  Antiviral drug sensitivity in ocular herpes simplex virus infection.

Authors:  M J Menage; E de Clercq; A van Lierde; V S Easty; J M Darville; S D Cook; D L Easty
Journal:  Br J Ophthalmol       Date:  1990-09       Impact factor: 4.638
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.